首页> 外文期刊>Advances in Diabetes and Metabolism >Inhibitory Effects of Methanol Stem Bark Extracts of Sterculia Setigera and Ficus Platyphylla on Hemoglobin Glycosylation and α-amylase
【24h】

Inhibitory Effects of Methanol Stem Bark Extracts of Sterculia Setigera and Ficus Platyphylla on Hemoglobin Glycosylation and α-amylase

机译:甲醇茎茎提取物的抑制作用术术造桃蛋白酶和榕属蛋白酶对血红蛋白糖基化和α-淀粉酶的抑制作用

获取原文
       

摘要

Diabetes Mellitus is a chronic metabolic disorder characterized by hyperglycemia due to abnormal insulin secretion, action or both. The synthetic available anti-diabetic drugs exhibited various adverse effects such as diarrhea, hypoglycemia. In recent years, scientists have turned their attention towards the medicinal plants which bear the rich source of metabolites which offer specific therapeutic function in the human body without any adverse effect. Sterculia setigera and Ficus platyphylla are medicinal plants that are used to treat various diseases and including diabetes traditionally. The present study is aimed at investigating the antidiabetic activity of the S. setigera and F. platyphylla methanol stem bark extracts. Phytochemical screening was determined using the standard method. In vitro studies were carried out using α-amylase and glycosylated hemoglobin inhibitory assay. The results of phytochemical constituents detected were flavonoids, Tannins, Steroids, Saponins, cardiac glycosides, Terpenoids, and Phenols. Inhibitory effects of both plant extracts were dose dependent against haemoglobin glycosylation and α-amylase. At highest concentration (25mg/ml), highest inhibitions were recorded in S. setigera (70.30%) and F. platyphylla (70.00%) which was comparable to Metformin (57. 2%). IC50 of Sterculia setigera (3.18mg/ml) and Ficus platyphylla (5.97mg/ml) were lower than metformin (8.84 mg/ml) against hemoglobin glycosylation. At concentration of (1.0mg/ml) S. setigera (72.21%) and F. platyphylla the (70.41%) showed the highest inhibitory effect which was not significantly different (p0.05) compared to Voglibose (83.47%). In the present study, the IC50 of both extracts were higher (0.64 and 0.69mg/ml) and not significantly comparable to the Voglibose (0.26mg/ml). In conclusion, this study suggests that Sterculia setigera and Ficus platyphylla methanol stem bark extract possess hypoglycaemic potentials. This justifies their ethnomedicinal use for the treatment of diabetes.
机译:糖尿病是一种慢性代谢紊乱,其特征是由于胰岛素分泌异常,动作或两者患者的高血糖。合成可用的抗糖尿病药物表现出各种不良反应,如腹泻,低血基血症。近年来,科学家们将注意力转向药用植物,该植物承受着丰富的代谢物来源,在没有任何不良影响的情况下提供特异性治疗功能。 Sterculia Setigera和Ficus platyphylla是用于治疗各种疾病和传统糖尿病的药用植物。本研究旨在调查S.Setigera和F.Platyphylla甲醇茎树皮提取物的抗糖尿病活性。使用标准方法测定植物化学筛选。使用α-淀粉酶和糖基化血红蛋白抑制试验进行体外研究。检测到的植物化学成分的结果是黄酮类化合物,单宁,类固醇,皂苷,心脏糖苷,三萜类化合物和酚。植物提取物的抑制作用依赖于血红蛋白糖基化和α-淀粉酶的剂量。在最高浓度(25mg / mL)中,在S.Sexergera(70.30%)和F. platyphylla(70.00%)中记录了最高抑制剂,其与二甲双胍(57.2%)相当。 STERCULIA SETIGERA(318mg / ml)和FICUS蛋白蛋白酶(5.97mg / ml)的IC50低于血红蛋白糖基化的二甲双胍(8.84mg / ml)。浓度(1.0mg / ml)S. setigera(72.21%)和F. platyphylla(70.41%)显示出与voglibose(83.47%)相比没有显着不同的抑制作用(P <0.05)。在本研究中,两种提取物的IC 50更高(0.64和0.69mg / ml),与voglibose(0.26mg / ml)显着不显着。总之,本研究表明,斯特鲁里亚·塞梅拉和榕属蛋白质甲醇干树皮提取物具有低血糖潜力。这证明了他们对治疗糖尿病的血统用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号